TD Cowen Maintains Buy on Versigent, Raises Price Target to $49
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $47 to $49.
TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $47 to $49.